Key points are not available for this paper at this time.
The aim of the study was to evaluate the polyphenol profile of Castanea sativa leaf methanolic extract and further evaluate its biological activities in vitro. After purification with an RP-18 resin, the extract was assessed for its polyphenol profile by UPLC-PDA-MS/MS, as well as for the antioxidant potential (ABTS, CUPRAC, ChA, ROS scavenging methods), anticancer, antiobesity, antidiabetic and antimicrobial potential. Eighteen polyphenols were identified and the dominant compounds were chestatin followed by quercetin 3-O-glucoside. The total phenolic content of the extract showed a value of 1426.55 mg/100 g d.w. The obtained preparation showed the ability to scavenge O2•− (0.067 mg/mL) and OH• (0.207 mg/mL) radicals and had a stronger anti-obesity than anti-diabetic effect. Additionally, this extract exhibited a strong anticancer activity against the Caco-2 line (153.54 µg/mL), with anti-migratory and anti-proliferative activity. In turn, among the tested strains, the highest activity was demonstrated against Staphylococcus aureus. Moreover, the effects demonstrated were strongly dependent on the content of polyphenols. In conclusion, C. sativa is a promising source of natural antioxidant, antibacterial, antiobesity, antidiabetic and chemopreventive compounds for food-pharma industry; however, further experimental studies are needed to validate its pharmacological properties.
Żurek et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: